Kabra Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE323K01017
  • NSEID:
  • BSEID: 524322
INR
31.00
0.63 (2.07%)
BSENSE

Mar 05

BSE+NSE Vol: 42.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 271637,
    "name": "Kabra Drugs",
    "stock_name": "Kabra Drugs",
    "full_name": "Kabra Drugs Ltd",
    "name_url": "stocks-analysis/kabra-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "31.00",
    "chg": 0.63,
    "chgp": "2.07%",
    "dir": 1,
    "prev_price": "30.37",
    "mcapval": "71.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524322,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE323K01017",
    "curr_date": "Mar 05",
    "curr_time": "",
    "bse_nse_vol": "42.44 k",
    "exc_status": "Active",
    "traded_date": "Mar 05, 2026",
    "traded_date_str": "2026 03 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kabra-drugs-271637-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Kabra Drugs Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-kabra-drugs-ltd-3829260",
        "imagepath": "",
        "date": "2026-02-09 23:16:20",
        "description": "Kabra Drugs Ltd is scheduled to declare its results on 13 February 2026...."
      }
    ],
    "total": 53,
    "sid": "271637",
    "stock_news_url": "https://www.marketsmojo.com/news/kabra-drugs-271637"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On March 7 2026",
      "datetime": "26-Feb-2026",
      "details": "Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday March 7 2026 at the Corporate Office of the Company situated at Chennai.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Feb-2026",
      "details": "Newspaper Advertisement of extract of unaudited financial results for the quarter ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter Ended 31St December 2025 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015",
      "datetime": "13-Feb-2026",
      "details": "Financial Results for the quarter ended 31st December 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "07 Mar 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Intimation for Intimation Of Board Meeting To Be Held On March 7 2026

26-Feb-2026 | Source : BSE

Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/03/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday March 7 2026 at the Corporate Office of the Company situated at Chennai.

Announcement under Regulation 30 (LODR)-Newspaper Publication

16-Feb-2026 | Source : BSE

Newspaper Advertisement of extract of unaudited financial results for the quarter ended on 31st December 2025.

Financial Results For The Quarter Ended 31St December 2025 Under Regulation 33 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015

13-Feb-2026 | Source : BSE

Financial Results for the quarter ended 31st December 2025.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

07 Mar 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available